CRYSTALLINE HYDRATED SODIUM SALT OF (E)-4,6-DICHLORO-3-(2-OXO-1-PHENYLPYRROLIDIN-3-YLIDENE METHYL)-1H-INDOLE-2-CARBOXYLIC ACID - Patent 0966463

(19)

(11)

EP 0 966 463 A1

(12)

(43)	Date of publication:
	29.12.1999 Bulletin 1999/52

(21)	Application number: 98913613.0

(22)	Date of filing: 03.03.1998

(51)

International Patent Classification (IPC):

A61P 25/ 04^{( . )}
A61P 25/ 00^{( . )}
A61P 43/ 00^{( . )}

A61K 31/ 404^{( . )}
A61P 25/ 28^{( . )}
C07D 403/ 06^{( . )}

(86)	International application number:
	PCT/EP1998/001146

(87)	International publication number:
	WO 1998/039327 (11.09.1998 Gazette 1998/36)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

05.03.1997 GB 19970004498

(71)	Applicant: GLAXO WELLCOME S.p.A.
	37100 Verona (IT)

(72)	Inventors:
	CIMAROSTI, Zadeo I-37100 Verona (IT) MARAGNI, Paolo I-37100 Verona (IT)

(74)	Representative: Filler, Wendy Anne, Dr., et al
	Glaxo Wellcome plc Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	CRYSTALLINE HYDRATED SODIUM SALT OF (E)-4,6-DICHLORO-3-(2-OXO-1-PHENYLPYRROLIDIN-3-YLIDENE METHYL)-1H-INDOLE-2-CARBOXYLIC ACID